{
  "retracted": false,
  "timestamp": 1086048000000,
  "updates": [
    {
      "timestamp": 1586335985482,
      "identifier": {
        "doi": "10.1038/nm0604-649c"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/nm988"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: CORRIGENDUM: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer"
}
